Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.58 Million SEK | 815.4% |
| 2022 | 1.15 Million SEK | -22.93% |
| 2021 | 1.5 Million SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.45 Million SEK | -0.69% |
| 2024 Q1 | 4.48 Million SEK | -57.59% |
| 2023 Q3 | 4.67 Million SEK | 382.46% |
| 2023 FY | 10.58 Million SEK | 815.4% |
| 2023 Q1 | 1.06 Million SEK | -8.13% |
| 2023 Q2 | 969 Thousand SEK | -8.76% |
| 2023 Q4 | 10.58 Million SEK | 126.35% |
| 2022 Q3 | 1.25 Million SEK | -6.99% |
| 2022 Q4 | 1.15 Million SEK | -7.52% |
| 2022 FY | 1.15 Million SEK | -22.93% |
| 2022 Q2 | 1.34 Million SEK | -6.54% |
| 2022 Q1 | 1.43 Million SEK | -4.13% |
| 2021 Q1 | 1 Million SEK | 0.0% |
| 2021 FY | 1.5 Million SEK | 0.0% |
| 2021 Q2 | 1.5 Million SEK | 50.0% |
| 2021 Q4 | 1.5 Million SEK | 0.0% |
| 2021 Q3 | 1.5 Million SEK | 0.0% |
| 2020 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.344% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.344% |
| Arcoma AB | 3.87 Million SEK | -173.225% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 95.46% |
| BICO Group AB (publ) | 1.85 Billion SEK | 99.429% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 93.629% |
| CellaVision AB (publ) | 64.7 Million SEK | 83.645% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -2230.837% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -487.889% |
| Dignitana AB (publ) | 19.1 Million SEK | 44.608% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -103.5% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.869% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -28.272% |
| Iconovo AB (publ) | 7.72 Million SEK | -36.985% |
| Integrum AB (publ) | 6.42 Million SEK | -64.721% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -5036.295% |
| Mentice AB (publ) | 9.55 Million SEK | -10.725% |
| OssDsign AB (publ) | 3.15 Million SEK | -235.937% |
| Paxman AB (publ) | 13.57 Million SEK | 22.019% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | 48.956% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -55.686% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | 66.711% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -145.75% |
| Senzime AB (publ) | 11.46 Million SEK | 7.726% |
| SpectraCure AB (publ) | 6.71 Million SEK | -57.541% |
| Stille AB | 62.94 Million SEK | 83.188% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 99.493% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | 66.339% |